The Sexually Transmitted Disease (STD) Self-Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for sexually transmitted disease (STD) self-testing has experienced significant growth recently. It is projected to increase from $1.38 billion in 2024 to $1.52 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%.
The global market for sexually transmitted disease (STD) self-testing is projected to reach $2.21 billion by 2029, growing at a compound annual growth rate of 9.8%.
Download Your Free Sample of the 2025 Sexually Transmitted Disease (STD) Self-Testing Market Report and Uncover Key Trends Now!The key drivers in the sexually transmitted disease (std) self-testing market are:
• Rising incidence of syphilis.
• Decline in consistent condom usage, leading to higher risks of STD infection.
• Benefits from STD self-testing such as early diagnosis.
• Preventive measures and prompt treatments enabled by STD self-testing.
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
The key trends in the sexually transmitted disease (std) self-testing market are:
• Increasing focus on developing advanced STD self-testing products, like over-the-counter sample collection kits, is a prevalent trend.
• The aim to promote early detection and quick treatment of infections is shaping the market.
• There's a rise in favorability towards at-home diagnostic tools providing confidentiality and convenience.
• A growing trend of pairing self-testing kits with reliable lab analysis is seen, to ensure accurate results and compliance with quality standards.
Major players in the sexually transmitted disease (std) self-testing market are:
• Abbott Laboratories
• Viatris Inc.
• Hologic Inc.
• OraSure Technologies Inc.
• LifeCell International
• LetsGetChecked Health Inc.
• Visby Medical Inc.
• Everlywell Inc.
• Guangzhou Wondfo Biotech Co. Ltd.
• NOWDiagnostics Inc.
• bioLytical Laboratories Inc.
• Atomo Diagnostics Limited
• myLAB Box Inc.
• BioSure UK Ltd.
• JAL Medical (S) Pte Ltd.
• TBD Health Inc.
• Recombigen Laboratories Private Limited
• Alpine Biomedicals Pvt. Ltd.
• Homed-IQ B.V.
• Newfoundland Diagnostics Pvt. Ltd.
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024